A Novel Adverse Event Associated with Olaparib Therapy in a Patient with Metastatic Breast Cancer

<div>(a) Rash after initiation of olaparib therapy. (b) Recurrence of rash after the second course of treatment with olaparib. (c) Third recurrence of rash after reinitiation of olaparib.</div>

Case Reports in Oncological Medicine

fig1

Figure 1

Figure 1: A Novel Adverse Event Associated with Olaparib Therapy in a Patient with Metastatic Breast Cancer 